http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2285989-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae340e00572753c0a042ff8b0f6dca49 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06139 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06026 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 |
| filingDate | 2000-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1507e4e0fa1ac80c15dbbac3c4047fbb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93e573ff727cea838e04fb32f9cc142c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4bdbf0df4491edbe48c1ea2be35c9b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09798705f23a84b4bc4d57b83d2ac3e4 |
| publicationDate | 2007-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2285989-T3 |
| titleOfInvention | NON-COVALENT INHIBITORS OF THE UROQUINASE AND THE FORMATION OF BLOOD VESSELS. |
| abstract | A compound with the ** formula **, in which: (a) X is selected from the group consisting of -S (O) 2-, N (R '') - S (O) 2-, - (C = O) -, -OC (= O) -, -NH-C (= O) -, -P (O) (R '') -, and a direct link, in which R '' is independently hydrogen, alkyl of 1 to 4 carbon atoms, aryl of 6 to 14 carbon atoms or aralkyl of 7 to 16 carbon atoms, with the exception that when X is -P (O) (R '') -, then R '' is not hydrogen; (b) R1 is selected from the group consisting of (1) alkyl of 1 to 12 carbon atoms that is optionally substituted with Y1 and / or Y2; (2) alkyl of 1 to 3 carbon atoms substituted with cycloalkyl of 3 to 8 carbon atoms which is optionally mono-, di- or tri-substituted with Y1, Y2 and / or Y3; (3) cycloalkyl of 3 to 15 carbon atoms which is optionally, mono-, di- or tri-substituted on the ring with Y1, Y2 and / or Y3; and (4) heterocycloalkyl of 4 to 10 ring atoms with the ring atoms selected from carbon and heteroatoms, wherein the heteroatoms are selected from the group consisting of oxygen, nitrogen, and S (O) i, wherein i is 0, 1 or 2, which is optionally mono-, di- or tri-substituted on the ring with Y1, Y2, and / or Y3; (5) heterocycle of 4 to 10 ring atoms with the ring atoms selected from carbon and heteroatoms. |
| priorityDate | 2000-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 164.